Literature DB >> 27373903

Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study.

Gabriella Moroni1, Andrea Doria2, Elisa Giglio3, Enrico Imbasciati4, Chiara Tani5, Margherita Zen2, Francesca Strigini6, Barbara Zaina7, Angela Tincani8, Mariele Gatto2, Federica de Liso9, Claudia Grossi10, Pier Luigi Meroni11, Gianfranca Cabiddu12, Piergiorgio Messa3, Pietro Ravani13, Marta Mosca5.   

Abstract

Retrospective studies reported a high incidence of maternal complications in pregnant women with lupus. In this paper we prospectively assessed the rate of risk and the risk factors of maternal outcome in women with stable lupus nephritis who received pre-pregnancy counseling. This prospective multicenter study includes 71 pregnancies in 61 women with lupus nephritis who became pregnant between 2006 and 2013. Complete renal remission was present before pregnancy in 56 cases (78.9%) and mild active nephritis in 15 cases. All women underwent a screening visit before pregnancy and were closely monitored by a multidisciplinary team. Lupus anticoagulant, serum C3 and C4 complement fractions, anti-DNA antibodies, anti-C1q antibodies, anticardiolipin IgG and IgM antibodies, anti-beta2 IgG and IgM antibodies were tested at screening visit, at first, second, third trimester of pregnancy, and one year after delivery. Renal flares of lupus during or after pregnancy, pre-eclampsia, and HELLP syndrome were defined as adverse maternal outcomes. Fourteen flares (19.7%), six cases of pre-eclampsia (8.4%) and two cases of HELLP (2.8%) occurred during the study period. All flares responded to therapy and the manifestations of pre-eclampsia and HELLP were promptly reversible. Low C3, high anti-DNA antibodies and predicted all renal flares. High anti-C1q antibodies and low C4 predicted early flares. The body mass index (BMI) was associated with increased risk of late flares. History of previous renal flares and the presence of clinically active lupus nephritis at conception did not increase the risk of renal flares during pregnancy. History of renal flares before pregnancy, arterial hypertension, and longer disease predicted pre-eclampsia/HELLP. In pregnant women with lupus nephritis adverse maternal outcomes were relatively common but proved to be reversible when promptly diagnosed and treated. Immunological activity, arterial hypertension and BMI may predispose to maternal complications. Published by Elsevier Ltd.

Entities:  

Keywords:  Lupus nephritis; Preeclampsia; Pregnancy; Renal flares; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 27373903     DOI: 10.1016/j.jaut.2016.06.012

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  26 in total

1.  Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Authors:  Jill P Buyon; Mimi Y Kim; Marta M Guerra; Sifan Lu; Emily Reeves; Michelle Petri; Carl A Laskin; Michael D Lockshin; Lisa R Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Jane E Salmon
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 8.237

Review 2.  [Adolescent rheumatism : The same but different].

Authors:  Sabine Adler
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

Review 3.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 4.  Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.

Authors:  Savino Sciascia; Massimo Radin; Jinoos Yazdany; Maria Tektonidou; Irene Cecchi; Dario Roccatello; Maria Dall'Era
Journal:  Rheumatol Int       Date:  2017-03-03       Impact factor: 2.631

Review 5.  Pregnancy in patients with systemic lupus erythematosus: a systematic review.

Authors:  Shumin Zhang; Xiao Han; Wenping Liu; Qiong Wen; Jibo Wang
Journal:  Arch Gynecol Obstet       Date:  2022-08-01       Impact factor: 2.493

6.  Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.

Authors:  Dongying Chen; Minxi Lao; Xiaoyan Cai; Hao Li; Yanfeng Zhan; Xiaodong Wang; Zhongping Zhan
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

7.  Clinical practice guideline on pregnancy and renal disease.

Authors:  Kate Wiles; Lucy Chappell; Katherine Clark; Louise Elman; Matt Hall; Liz Lightstone; Germin Mohamed; Durba Mukherjee; Catherine Nelson-Piercy; Philip Webster; Rebecca Whybrow; Kate Bramham
Journal:  BMC Nephrol       Date:  2019-10-31       Impact factor: 2.388

Review 8.  Reproductive health and pregnancy in women with chronic kidney disease.

Authors:  Kate S Wiles; Catherine Nelson-Piercy; Kate Bramham
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

Review 9.  Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines.

Authors:  Kimberly Blom; Ayodele Odutayo; Kate Bramham; Michelle A Hladunewich
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

10.  The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus.

Authors:  Katarina Bremme; Sonja Honkanen; Iva Gunnarsson; Roza Chaireti
Journal:  Lupus       Date:  2021-04-12       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.